Cargando…
Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B
BACKGROUND: Development of the hepatitis B virus (HBV) rtA181T/sW172* mutant could occur during prolonged lamivudine (LAM) therapy, conferring cross resistance to adefovir. Recent studies demonstrated an increased oncogenic potential of this mutant in NIH3T3 cells. In this study, we aimed to investi...
Autores principales: | Yeh, Chau-Ting, Chen, Tiffany, Hsu, Chao-Wei, Chen, Yi-Cheng, Lai, Ming-Wei, Liang, Kung-Hao, Chen, Tse-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184121/ https://www.ncbi.nlm.nih.gov/pubmed/21933446 http://dx.doi.org/10.1186/1471-2407-11-398 |
Ejemplares similares
-
Biological characteristics of the rtA181T/sW172* mutant strain of Hepatitis B virus in animal model
por: Dai, Jie, et al.
Publicado: (2012) -
Antiviral efficacy of entecavir for hepatitis B virus rtA181V/T mutants
por: Li, Ping, et al.
Publicado: (2017) -
The Occurrence of rtA194T Mutant After Long-Term Lamivudine Monotherapy Remains Sensitive to Tenofovir Disoproxil Fumarate: A Case Report
por: Li, Jing, et al.
Publicado: (2021) -
Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S/S gene with the sW172* mutation
por: Lai, M-W, et al.
Publicado: (2016) -
Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi
por: Lai, Ming-Wei, et al.
Publicado: (2020)